低分子肝素治疗脑梗死的疗效分析

The clinical effects of Low Molecular Heparin in the treatment of brain block

目的:探讨低分子肝素治疗脑梗死的疗效。方法:选择2008年1月～2010年12月120例脑梗死患者,随机分为治疗组与对照组,每组各60例,治疗组用低分子肝素进行治疗,对照组进行常规治疗,对比其临床疗效。结果:经过治疗后,治疗组总有效率为98.33%(59/60),对照组总有效率为78.33%(47/60),差异具有统计学意义(P<0.05)。对照组治疗前神经功能缺损评分为(24.12±3.2)分,治疗组为(24.17±3.1)分,两组治疗前评分差异无统计学意义(P>0.05);治疗组治疗后神经功能缺损评分为(14.1±3.2)分,明显低于对照组[(19.7±4.5)分],两组差异有高度统计学意义(P<0.01),治疗组神经功能的恢复明显优于对照组。结论:低分子肝素治疗脑梗死,疗效显著,值得应用推广。

Objective： To investigate the clinical effect of Low Molecular Heparin in the treatment of brain block.Methods： 120 brain block patients from January 2008 to December 2010 were divided into the treatment group（60 cases） and the control group（60 cases）.The patients in the treatment group were given Low Molecular Heparin therapy while those in the control group were given regular therapy,the clinical effect of the two groups were compared after treatment.Results： The total efficacy rate of the treatment group was 98.33%（59/60） while that of control group was 78.33%（47/60）,and the NIHSS of two groups before treatment had no significant difference（P〉0.05）,NIHSS of group of treatment group was lower than control group[（14.1±3.2）scores vs（19.7±4.5） scores],the difference was significant（P〈0.05）.Conclusion： The clinical effect of low molecular heparin in the treatment of brain block is significant,it is worthy of application